The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...

Sanofi reports Q1 growth with Altuviiio sales doubling to €251M and Dupixent reaching €3.5B; company terminates two cancer ...

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

Sanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in Times Square. A patient advocacy organization, We Are ILL redefines what “sick” looks like by making the multiple ...

LONDON The £10,000 Aventis Prize for Science Books — sometimes called science's Booker Prize — has this year been won by Robert Kunzig's Mapping the Deep – The Extraordinary Story of Ocean Science.

Sanofi has managed the daunting task faced by managers worldwide: hauling its employees back to the office with minimal fuss. That’s an impressive feat for a company that said last year it was ...